Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 15, 2011

Premium

Caprotec Bioanalytics this week appointed Marc Voigt as managing director, chief financial officer, and chief operating officer.

Voigt comes to the company from Medical Enzymes where he was chief financial officer and chief business officer. Prior to that he was chief financial officer and chief business officer at Revotar Biopharmaceuticals.


Thermo Fisher Scientific said this week it has elected Lars Rebien Sorensen to its board of directors.

Sorensen is president and CEO of healthcare company Novo Nordisk. He is also a member of the supervisory board of Bertelsmann and a director of Dong Energy.


Robert McBurney this week was named CEO of the Accelerated Cure Project for Multiple Sclerosis.

Formerly the CEO of Cambridge Neuroscience, McBurney has held senior positions at firms including BG Medicine and TheraGenetics and is the co-founder of Differential Proteomics and Optimal Medicine.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.